Differential Expression of Human Spasmolytic Polypeptide (Trefoil Factor Family-2) in Pancreatic Carcinomas, Ampullary Carcinomas, and Mucin-Producing Tumors of the Pancreas (original) (raw)
REFERENCES
Thim L: Trefoil peptides: a new family of gastrointestinal molecules. Digestion 55:353–360, 1994 Google Scholar
Wright NA, Hoffmann W, Otto WR, Rio MC, Thim L: Rolling in the clover: Trefoil factor family (TFF)-domain peptides, cell migration and cancer. FEBS Lett 408:121–123, 1997 Google Scholar
Jørgensen KH, Thim L, Jacobsen HE: Pancreatic spasmolytic polypeptide (PSP): 1. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul Pept 3:207–219, 1982 Google Scholar
Jørgensen KD, Diamant B, Jørgensen H, Thim L: Pancreatic spasomlytic polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects. Regul Pept 3:231–243, 1982 Google Scholar
Tomasetto C, Rio M, Gautier C, Wolf C, Hareuveni M, Chambon P, Lathe R: hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 9:407–414, 1990 Google Scholar
Hanby AM, Poulsom R, Singh S, Elia G, Jeffery RE, Wright NA: Spasmolytic polypeptide is a major antral peptide: Distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 105:1110–1116, 1993 Google Scholar
Podolsky DK, Devaney KL, Stow JL, Oates P, Murgue B, Debeaumont M, Sands BE, Mahida YR: Identification of human trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 268:6694–6702, 1993 Google Scholar
Elia G, Chinery R, Hanby AM, Poulsom R, Wright NA: The production and characterization of a new monoclonal antibody to the trefoil peptide human spasmolytic polypeptide. Histochemical J 26:644–647, 1994 Google Scholar
Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky D: Trefoil peptides promote epitherial migration through a transforming growth factor _β_-independent pathway. J Clin Invest 94:376–383, 1994 Google Scholar
Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M, Boulton RA, Thim L, Hanby AM: Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 108:108–116, 1995 Google Scholar
Babyatsky MW, DeBeaumont M, Thim L, Podolsky DK: Oral trefoil peptides protect against ethanol-and indomethacin-induced gastric injury in rats. Gastroenterology 110:489–497, 1996 Google Scholar
Poulsom R, Wright N: Trefoil peptides: A new recognized family of epithelial mucin-associated molecules. Am J Physiol 265:G205–G213, 1993 Google Scholar
Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK: Trefoil peptide protection of intestinal epithelial barrier function: Cooperative interaction with mucin glycoprotein. Gastroenterology 109:516–523, 1995 Google Scholar
Tanaka S, Podolsky DK, Engel E, Guth PH, Kaunitz JD: Human spasmolytic polypeptide decreases proton permeation through gastric mucus in vivo and in vitro. Am J Physiol 272:G1473–G1480, 1997 Google Scholar
Masiakowski P, Breathnach R, Bioch J, Gannon F, Krust A, Chambon P: Cloning of cDNA sequences of hormone-related genes from the MCF-7 cancer cell line. Nucleic Acid Res 10:7895–7903, 1982 Google Scholar
Hoosein NM, Thim L, Jorgensen KH, Brattain MG: Growth stimulation effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumour cells. FEBS Lett 247:303–306, 1989 Google Scholar
Luqmani Y, Bennett C, Paterson I, Corbishley CM, Rio MC, Chambon P: Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int J Cancer 44:806–812, 1989 Google Scholar
Henry JA, Bennett MK, Piggott NH, Levett DL, May FE, Westley BR: Expression of the pNR-3/pS2 protein in diverse human epitherial tumours. Br J Cancer 64:677–682, 1991 Google Scholar
Theisinger B, Welter C, Seitz G, Rio MC, Lathe R, Chambon P, Blin N: Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. Eur J Cancer 27:770–773, 1991 Google Scholar
Luqmani YA, Ryall G, Shousha S, Coombes RC: An immunohistochemical survey of pS2 expression in human epitherial cancers. Int J Cancer 50:302–304, 1992 Google Scholar
Welter C, Theisinger B, Seitz G, Tomasetto C, Rio M, Chambon P, Blin N: Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab Invest 66:187–192, 1992 Google Scholar
Kloppel G, Iingenthal G, Vonbulow M, Kern HF: Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: Studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases. Histopathology 9:841–856, 1985 Google Scholar
Itai Y, Ohhashi K, Nagai H, Murakami Y, Kokubo T, Makita K, Ohtomo K: “Ductectatic” mucinous cystadenoma and cystadenocarcinoma of the pancreas. Radiology 161:697–700, 1986 Google Scholar
Rickaert F, Cremer M, Deviere J, Tavares L, Lambilliotte JP, Schröder S, Wurbs D, Klöppel G: Intraductal mucin-hypersecreting neoplasms of the pancreas: A clinicopathological study of eight patients. Gastroenterology 101:512–519, 1991 Google Scholar
Yanagisawa A, Ohashi K, Hori M, Takagi K, Kitagawa K, Sugano H, Kato Y: Ductectatic-type mucinous cystadenoma and cystadenocarcinoma of the human pancreas: A novel clinicopathological entity. Jpn J Cancer Res 84:474–479, 1993 Google Scholar
Yamaguchi K, Ogawa Y, Chijiwa K, Tanaka M: Mucin-hypersecreting tumors of the pancreas: Assessing the grade of malignancy preoperatively. Am J Surg 171:427–431, 1996 Google Scholar
Ohshio G, Yoshioka H, Manabe T, Sakahara H, Yamabe H, Imamura M, Inoue M, Tanaka N, Nakada H, Yamashina I: Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract. J Cancer Res Clin Oncol 29:325–330, 1994 Google Scholar
Wright NA, Poulsom R, Stamp GWH, Hall PA, Jeffery RE, Longcroft JM, Rio MC, Tomasetto C, Chambon P: Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 162:279–284, 1990 Google Scholar